Anatomic Pathology

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion™ (research use only (RUO) in the US, CE-IVDD-marked in...

OREM, UT, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Techcyte, a leader in AI-powered digital pathology, has signed a distribution agreement with Hamamatsu Corporation (U.S.). This agreement enables Techcyte to streamline access to...

Philips: Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health...

"The main business of humanity is to do a good job of being human beings," said Paul, "not to serve as appendages to machines, institutions, and systems." If you have not read Player Piano, it is a good read. I read it many years ago...

SINGAPORE, May 1, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic...